Tag: Parliamentary Question

  • Matthew Offord – 2016 Parliamentary Question to the Home Office

    Matthew Offord – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Matthew Offord on 2016-10-10.

    To ask the Secretary of State for the Home Department, what estimate her Department has made of the number of UK nationals who have travelled overseas to engage in terrorist activity.

    Mr Ben Wallace

    The Government takes the threat posed by UK nationals who travel overseas to engage in terrorist activity extremely seriously. We are particularly concerned about those who travel to Syria and Iraq to fight; around 850 linked individuals have travelled to engage in the conflict since it began, and just under half of those have returned.

    People seeking to travel to engage in terrorist activity should be in no doubt we will take the strongest possible action to protect our national security.

  • Sadiq Khan – 2015 Parliamentary Question to the Department of Health

    Sadiq Khan – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sadiq Khan on 2015-10-29.

    To ask the Secretary of State for Health, on how many occasions in each of the last five years bed occupancy rates reached (a) 85, (b) 90, (c) 95 and (d) 100 per cent in each hospital trust in London.

    Jane Ellison

    Official statistics for average daily occupancy rates for beds open overnight are published every quarter by NHS England on their website at the following address:

    https://www.england.nhs.uk/statistics/statistical-work-areas/bed-availability-and-occupancy/

    “

  • Lord Wills – 2015 Parliamentary Question to the Department of Health

    Lord Wills – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Wills on 2015-11-19.

    To ask Her Majesty’s Government what assessment they have made in the Comprehensive Spending Review of the expected incidence of mesothelioma over the next fifty years in children born since 2010 in the constituencies covered by the Northern Powerhouse.

    Lord Prior of Brampton

    The Spending Review has not made assessments on the incidence, or expected incidence, of mesothelioma in constituencies covered by the Northern Powerhouse.

  • Stephen Timms – 2016 Parliamentary Question to the Department for Transport

    Stephen Timms – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Stephen Timms on 2015-12-17.

    To ask the Secretary of State for Transport, what discussions he has had with his German counterpart on the future operation of Deutsche Bahn services between Stratford International and Germany.

    Claire Perry

    I recognise the international importance of the HS1 network in allowing high-speed rail services from London to reach Europe, whilst noting that no international services currently serve Stratford International station. Eurostar, in which the government recently sold its 40% stake, accesses the HS1 network on an open access basis and is not subject to the terms of a franchise agreement or a contract let by government. Government has no power to direct or specify that Eurostar stops at Stratford International station. A decision made by Eurostar not to serve Stratford International would be as a result of commercial imperatives and priorities, for example, the potential revenue derived from customers using the station or the increased journey time which a further stop would involve. It would not be appropriate for government to interfere with that decision-making process. I have not received any recent representations on this matter from potential or actual train operators; who in any event, should address their questions to HS1 Ltd, as the infrastructure manager, in the first instance; nor have I held any discussions with Eurostar on the matter of services to Stratford.

    Regarding any aspirations of Deutsche Bahn to commence operation of international services from St Pancras International, this is rightly a matter for HS1 Ltd as the infrastructure manager, who I understand have held discussions with a number of potential new entrants, including Deutsche Bahn. It would not be appropriate to comment on any ongoing commercial discussions between those parties.

  • Jim Shannon – 2016 Parliamentary Question to the Ministry of Defence

    Jim Shannon – 2016 Parliamentary Question to the Ministry of Defence

    The below Parliamentary question was asked by Jim Shannon on 2016-01-27.

    To ask the Secretary of State for Defence, what recent steps his Department has taken in conjunction with NATO to ensure flexibility in NATO’s capacity to respond to hostile actions.

    Mr Julian Brazier

    The UK was one of the driving forces behind NATO’s Readiness Action Plan (RAP), agreed at the Wales Summit, which includes tripling the strength of the NATO Response Force (NRF); the creation of a Very High Readiness Joint Task Force (VJTF) that is able to deploy at very short notice; and enhancing NATO’s Standing Naval Forces.

    The UK is fully involved with NATO work to improve the movement of troops and logistic support to the enhanced NRF and VJTF although improvements to and development of road networks remain the responsibility of each member nation.

    NATO Allies regularly discuss the progress of the RAP and the capabilities and deployability of our forces; we will do so again at the NATO Defence Ministerial meeting this month.

    The UK will contribute to the VJTF in every year between now and 2021 including: a 1,000 strong battle group for the Spanish-led Land VJTF in 2016; we will act as the Land VJTF lead nation in 2017, with 3,000 UK personnel; and in 2020 we will provide a 1,000 battle group to the Polish-led VJTF

  • Angela Smith – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    Angela Smith – 2016 Parliamentary Question to the Department for Environment, Food and Rural Affairs

    The below Parliamentary question was asked by Angela Smith on 2016-02-24.

    To ask the Secretary of State for Environment, Food and Rural Affairs, whether her Department plans to make an assessment of the environmental effects of the disposal of imported (a) animal blood, faeces and urine and (b) other biological by-products in rural areas of the UK.

    Rory Stewart

    We have no plans to make such an assessment.

  • Hannah Bardell – 2016 Parliamentary Question to the HM Treasury

    Hannah Bardell – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Hannah Bardell on 2016-03-15.

    To ask Mr Chancellor of the Exchequer, whether officials of (a) HM Revenue and Customs, (b) Border Force and (c) trading standards services are being trained in the use of Codentify to authenticate tobacco products.

    Damian Hinds

    Tobacco products classified as ‘illicit’ in the UK include anything on which duty has not been paid but should have been paid. This includes counterfeit products, brands manufactured legally overseas but not legally sold in the UK, and genuine products originating in the UK and overseas but diverted from legitimate supply chains by criminals. Because of this, HM Revenue and Customs (HMRC) officers use a variety of ways to identify illicit product. Testing product authenticity is one mechanism.

    To test product authenticity, HMRC uses identifiers required by legislation, for example, Fiscal Marks which manufacturers are required to print on specified tobacco products to show they are UK duty paid, as well as voluntary tools used by the manufacturers. One such voluntary tool is Codentify.

    Codentify was developed and introduced by the major tobacco manufacturers on their own initiative through the Digital Coding and Tracking Association (DCTA). HMRC played no part in the development or introduction of the system nor did HMRC require that it be introduced. Codentify codes already feature on packs and are there regardless of any HMRC use of them. HMRC took a policy decision, in line with the commitment to tackle illicit tobacco, to examine whether these existing codes could provide a useful additional tool to help officers authenticate product in the field.

    The trial is concerned only with the use of Codentify for product authentication, and no other aspect of the system is being used or evaluated. Codentify requires no specialist equipment or training. Officers are provided with basic guidance and access to an online system. No charge is made for use of the system and, as no procurement was needed, there was no requirement for HMRC to run a tender exercise. As this is a trial only, no Ministerial approval was required or has been sought.

    A number of HMRC officers have been given access to the system and trained by HMRC colleagues. The time spent on this activity is minimal and is estimated to be less than one staff year in total.

    HMRC has explained the use of Codentify as a potential product authentication tool to colleagues in Border Force and Trading Standards. However, they have not provided training to any officers in those organisations.

    The EU Tobacco Products Directive introduces a requirement for a pan European security feature and track and trace systems. The European Commission, working with Member States, is considering proposals and have yet to determine any technical specifications,

    HMRC is aware of a wide range of potential track and trace and security feature solutions on the market. They are not evaluating, and, given the current position on the Directive, could not evaluate any products against its requirements. The aspects of Codentify being used are entirely separate from the requirements of the Directive.

    In accordance with regulatory requirements, when technical specifications are determined, HMRC will ensure that any evaluation against them ensures no unfair competitive advantage or obstacles to competition.

  • Jim Shannon – 2016 Parliamentary Question to the Department of Health

    Jim Shannon – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2016-04-20.

    To ask the Secretary of State for Health, what discussions he has had with the Royal College of Nursing on the use of nirolumab and ipilimumab to treat skin cancer.

    George Freeman

    We have had no such discussions.

    Nivolumab (Opdivo) in combination with ipilimumab (Yervoy) does not currently have a marketing authorisation in the United Kingdom for treating advanced or unresectable melanoma.

    The National Institute for Health and Care Excellence (NICE) is currently appraising nivolumab in combination with ipilimumab for the treatment of advanced, unresectable melanoma. NICE currently expects to publish final guidance in September 2016.

    In the absence of guidance from NICE, it is for commissioners to make decisions on whether to fund new medicines based on an assessment of the available evidence.

  • Jonathan Reynolds – 2016 Parliamentary Question to the Department of Health

    Jonathan Reynolds – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jonathan Reynolds on 2016-05-23.

    To ask the Secretary of State for Health, how many patients on assessment and treatment units have been diagnosed with mental health conditions in the last 12 months.

    Alistair Burt

    Access to an independent mental health advocacy (IMHA) is a statutory right for people detained under most sections of the Mental Health Act, subject to Guardianship or on a community treatment order. We would expect Assessment and Treatment Units to follow their statutory obligations to ensure patients have access to an IMHA where appropriate.

    The Learning Disability Assuring Transformation statistics data shows that of the 2,565 inpatients at the end of April 2016, 600 patients had a main diagnostic category of mental illness on admission.

    Data on the numbers of formal complaints made about patient care; the management of assessment and treatment units; access to autism-specialist services and access to occupational and speech and language therapy are not held centrally. However, NHS England, Association of Directors of Adult Social Services and Local Government Association, published in October 2015, a Service Model for commissioners of health and social care services. This model sets out that when people are admitted to inpatient settings services should seek to minimise their length of stay and any admissions should be supported by a clear rationale of planned assessment and treatment with measurable outcomes. We would therefore expect all patients, irrespective of inpatient setting, to have access to the treatment and therapeutic interventions they require.

  • Lord Wills – 2016 Parliamentary Question to the Department for Education

    Lord Wills – 2016 Parliamentary Question to the Department for Education

    The below Parliamentary question was asked by Lord Wills on 2016-07-18.

    To ask Her Majesty’s Government in how many schools Design and Technology is not part of the curriculum.

    Lord Nash

    Design and Technology (D&T) is part of the national curriculum, and is therefore a compulsory subject in maintained schools for pupils aged 5 to 14. The national curriculum is a benchmark of an excellent, academically rigorous education that academies can use and improve upon. The Department does not collect information on how many schools do not include D&T as part of their curriculum.